Dio Tree
PrivateLast Round
Seed
Dec 1, 2022
Total Funding Raised
$400,000
Company Overview
Dio Tree operates in Healthcare & Life Sciences and is based in Nazareth. Its latest recorded funding round was a Seed round in December 2022.
Dio Tree is a biotechnology company that develops a novel, first-in-class, small molecule for the treatment of ovarian cancer by inhibiting the DIO3 enzyme.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dio Tree Comparables
Compare Dio Tree with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Algok Bio, Inc. | 75% | |
| OnCusp | 71% | |
| Zentalis | 65% |
For institutional investors. Book with your work email.
Dio Tree Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Dio Tree Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| NGT HealthCare II | Seed |
| Arieli Group | Seed |
| Hadasit - Hadassah Medical Center's Technology Transfer Company | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2022
$400K raised from Arieli Group, NGT HealthCare II, and others.
For institutional investors. Book with your work email.
Dio Tree Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dio Tree's valuation, stock price, and market status.
Is Dio Tree a public or private company?
Dio Tree is a private company.
What is the current stock price of Dio Tree?
Dio Tree is a private company, so its shares have no public market price. Caplight tracks Dio Tree's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dio Tree worth (valuation)?
Valuation information for Dio Tree is not publicly available.
Can I buy Dio Tree stock?
Dio Tree shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dio Tree's last funding round?
Dio Tree's most recent funding round was Seed on December 1, 2022.
Who are the main investors in Dio Tree?
Key investors in Dio Tree include Israel Innovation Authority, NGT HealthCare II, Arieli Group, Hadasit - Hadassah Medical Center's Technology Transfer Company.
Will Dio Tree IPO soon?
No public IPO plans have been announced for Dio Tree.
How can I track Dio Tree secondary market activity?
Caplight tracks bids, offers, and trades in Dio Tree's shares on secondary markets.